84年鼠女哪年财运最旺,857comvvv色九欧美激情|85PO_87国产精品欲av国产av资源

[1]田佳慶,劉良燕,彭鵬,等.基于“成骨-成血管”理論探討全身振動(dòng)療法治療激素性股骨頭壞死的效果及作用機(jī)制[J].中醫(yī)正骨,2024,36(09):59-68,82.
 TIAN Jiaqing,LIU Liangyan,PENG Peng,et al.Efficacy and mechanism of whole body vibration therapy in treatment of steroid-induced osteonecrosis of the femoral head:a osteogenesis-angiogenesis theory-based experimental study[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2024,36(09):59-68,82.
點(diǎn)擊復(fù)制

基于“成骨-成血管”理論探討全身振動(dòng)療法治療激素性股骨頭壞死的效果及作用機(jī)制()
分享到:

《中醫(yī)正骨》[ISSN:1001-6015/CN:41-1162/R]

卷:
第36卷
期數(shù):
2024年09期
頁碼:
59-68,82
欄目:
技術(shù)研究
出版日期:
2024-09-20

文章信息/Info

Title:
Efficacy and mechanism of whole body vibration therapy in treatment of steroid-induced osteonecrosis of the femoral head:a osteogenesis-angiogenesis theory-based experimental study
作者:
田佳慶1劉良燕2彭鵬1林錕1陸舜1何憲順1魏騰飛1何敏聰3欽逸仙4何偉3魏秋實(shí)3
(1.廣州中醫(yī)藥大學(xué)第三臨床醫(yī)學(xué)院,廣東 廣州 510006; 2.揭西縣中醫(yī)醫(yī)院,廣東 揭西 515400; 3.廣州中醫(yī)藥大學(xué)第三附屬醫(yī)院,廣東 廣州 510378; 4.紐約州立大學(xué)石溪分校,紐約 11794-5281)
Author(s):
TIAN Jiaqing1LIU Liangyan2PENG Peng1LIN Kun1LU Shun1HE Xianshun1WEI Tengfei1HE Mincong3QIN Yixian4HE Wei3WEI Qiushi3
1.The Third Clinical Medical College of Guangzhou University of Chinese Medicine,Guangzhou 510006,Guangdong,China 2.Jiexi Hospital of Traditional Chinese Medicine,Jiexi 515400,Guangdong,China 3.The Third Affiliated Hospital of Guangzhou University of Chinese Medicine,Guangzhou 510378,Guangdong,China 4.State University of New York at Stony Brook,New York 11794-5281,USA
關(guān)鍵詞:
股骨頭壞死 糖皮質(zhì)激素 全身振動(dòng)療法 骨生成 血管生成 H型血管 Piezo1蛋白
Keywords:
femur head necrosis glucocorticoids whole body vibration therapy osteogenesis angiogenesis type H blood vessels Piezo1 protein
摘要:
目的:觀察全身振動(dòng)療法(whole body vibration therapy,WBVT)治療激素性股骨頭壞死(steroid-induced osteonecrosis of the femoral head,SONFH)的效果,并探討其治療SONFH的作用機(jī)制。方法:將50只SD大鼠隨機(jī)分為空白組、模型組、WBVT組、Yoda1組、WBVT聯(lián)合蜘蛛毒液肽(Grammostola spatulata mechanotoxin 4,GsMTx4)組。模型組、WBVT組、Yoda1組、WBVT聯(lián)合GsMTx4組大鼠采用脂多糖聯(lián)合甲潑尼龍琥珀酸鈉構(gòu)建SONFH模型。造模后,WBVT組使用WBVT干預(yù),Yoda1組使用Piezo1蛋白激動(dòng)劑Yoda1干預(yù),WBVT聯(lián)合GsMTx4組使用WBVT和Piezo1蛋白抑制劑GsMTx4干預(yù)。干預(yù)結(jié)束后,進(jìn)行大鼠股骨頭組織病理學(xué)觀察(計(jì)算股骨頭空骨陷窩率)、骨微結(jié)構(gòu)觀察,以及股骨頭內(nèi)Piezo1、骨形態(tài)發(fā)生蛋白2(bone morphogenetic protein 2,BMP2)、Runt相關(guān)轉(zhuǎn)錄因子2(Runt-related transcription factor 2,Runx2)、低氧誘導(dǎo)因子-1α(hypoxia-inducible factor-1α,HIF-1α)、血管內(nèi)皮生長(zhǎng)因子(vascular endothelial growth factor,VEGF)、分化簇31(cluster of differentiation 31,CD31)/內(nèi)皮粘蛋白(endomucin,EMCN)蛋白表達(dá)量檢測(cè)。結(jié)果:①大鼠股骨頭組織病理學(xué)觀察結(jié)果。空白組大鼠的股骨頭內(nèi)骨小梁致密且排列整齊。與空白組相比,模型組大鼠股骨頭內(nèi)的骨小梁較為稀疏,骨小梁細(xì)小、不連續(xù),且排列紊亂。與模型組相比,WBVT組和Yoda1組大鼠的股骨頭內(nèi)骨小梁數(shù)量增多,排列較為整齊。與WBVT組相比,WBVT聯(lián)合GsMTx4組大鼠的股骨頭內(nèi)骨小梁排列則較為紊亂。模型組、WBVT組、Yoda1組、WBVT聯(lián)合GsMTx4組大鼠的股骨頭空骨陷窩率均高于空白組(P=0.000,P=0.000,P=0.000,P=0.000),WBVT組、Yoda1組大鼠的股骨頭空骨陷窩率均低于模型組(P=0.000,P=0.000),WBVT聯(lián)合GsMTx4組大鼠的股骨頭空骨陷窩率高于WBVT組(P=0.000)。②大鼠股骨頭骨微結(jié)構(gòu)觀察結(jié)果。WBVT組和Yoda1組大鼠的股骨頭骨體積分?jǐn)?shù)、骨小梁厚度、骨小梁數(shù)量、骨小梁分離度與空白組的差異均無統(tǒng)計(jì)學(xué)意義(P=0.213,P=0.081,P=0.384,P=0.471; P=0.435,P=0.131,P=0.104,P=0.126)。模型組和WBVT聯(lián)合GsMTx4組大鼠的股骨頭骨體積分?jǐn)?shù)、骨小梁厚度、骨小梁數(shù)量均低于空白組(P=0.000,P=0.000,P=0.000; P=0.000,P=0.000,P=0.000),骨小梁分離度均高于空白組(P=0.000,P=0.000)。WBVT組和Yoda1組大鼠的股骨頭骨體積分?jǐn)?shù)、骨小梁厚度、骨小梁數(shù)量均高于模型組(P=0.000,P=0.002,P=0.000; P=0.000,P=0.007,P=0.014),骨小梁分離度均低于模型組(P=0.000,P=0.000)。WBVT組大鼠的股骨頭骨體積分?jǐn)?shù)、骨小梁厚度、骨小梁數(shù)量、骨小梁分離度與Yoda1組的差異均無統(tǒng)計(jì)學(xué)意義(P=0.194,P=0.223,P=0.332,P=0.071)。WBVT聯(lián)合GsMTx4組大鼠的股骨頭骨體積分?jǐn)?shù)、骨小梁厚度、骨小梁數(shù)量均低于WBVT組(P=0.002,P=0.021,P=0.000),骨小梁分離度高于WBVT組(P=0.000)。③大鼠股骨頭內(nèi)Piezo1、BMP2、Runx2、HIF-1α、VEGF蛋白表達(dá)量檢測(cè)結(jié)果。WBVT組和Yoda1組大鼠股骨頭內(nèi)Piezo1、BMP2、Runx2、HIF-1α、VEGF蛋白表達(dá)量與空白組的差異均無統(tǒng)計(jì)學(xué)意義(P=0.061,P=0.122,P=0.773,P=0.814,P=0.991; P=0.112,P=0.071,P=0.955,P=0.749,P=0.915)。模型組和WBVT聯(lián)合GsMTx4組大鼠股骨頭內(nèi)Piezo1、BMP2、Runx2、HIF-1α、VEGF蛋白表達(dá)量均低于空白組(P=0.000,P=0.000,P=0.000,P=0.000,P=0.000; P=0.000,P=0.000,P=0.000,P=0.000,P=0.000)。WBVT組和Yoda1組大鼠股骨頭內(nèi)Piezo1、BMP2、Runx2、HIF-1α、VEGF蛋白表達(dá)量均高于模型組(P=0.000,P=0.000,P=0.000,P=0.000,P=0.000; P=0.000,P=0.000,P=0.000,P=0.000,P=0.000)。WBVT組大鼠股骨頭內(nèi)Piezo1、BMP2、Runx2、HIF-1α、VEGF蛋白表達(dá)量與Yoda1組的差異均無統(tǒng)計(jì)學(xué)意義(P=0.962,P=0.179,P=0.214,P=0.990,P=0.975)。WBVT聯(lián)合GsMTx4組大鼠股骨頭內(nèi)Piezo1、BMP2、Runx2、HIF-1α、VEGF蛋白表達(dá)量均低于WBVT組(P=0.000,P=0.000,P=0.000,P=0.000,P=0.000)。④大鼠股骨頭內(nèi)CD31/EMCN蛋白表達(dá)量檢測(cè)結(jié)果。模型組和WBVT聯(lián)合GsMTx4組大鼠股骨頭內(nèi)CD31/EMCN表達(dá)量均低于空白組(P=0.000,P=0.000)。WBVT組和Yoda1組大鼠股骨頭內(nèi)CD31/EMCN表達(dá)量與空白組的差異均無統(tǒng)計(jì)學(xué)意義(P=0.412,P=0.991)。WBVT組和Yoda1組大鼠股骨頭內(nèi)CD31/EMCN表達(dá)量均高于模型組(P=0.000,P=0.000)。WBVT聯(lián)合GsMTx4組大鼠股骨頭內(nèi)CD31/EMCN表達(dá)量低于WBVT組(P=0.000)。結(jié)論:WBVT可以促進(jìn)股骨頭壞死組織修復(fù),其作用機(jī)制可能與上調(diào)Piezo1蛋白的表達(dá)影響HIF-1α/VEGF軸,進(jìn)而促進(jìn)股骨頭內(nèi)H型血管的生成、改善股骨頭血供有關(guān)。
Abstract:
Objective:To observe the outcomes of whole body vibration therapy(WBVT)in treatment of steroid-induced osteonecrosis of the femoral head(SONFH),and to explore its underlying mechanism.Methods:Fifty Sprague-Dawley(SD)rats were randomized into blank group,model group,WBVT group,Yoda1 group,WBVT combined Grammostola spatulata mechanotoxin 4(GsMTx4)group.The rats in model group,WBVT group,Yoda1 group,WBVT combined GsMTx4 group were intervened by lipopolysaccharide and methylprednisolone sodium succinate for inducing SONFH.After successful modeling,the rats in WBVT group,Yoda1 group and WBVT combined GsMTx4 group were further intervened with WBVT,Yoda1(a Piezo1 agonist),as well as WBVT and GsMTx4(a Piezo1 inhibitor),respectively.After the end of intervention,the histopathological changes of the femur head were observed and the percentage of empty lacunae in femur head were calculated; meanwhile,the bone microstructure of the femur head was observed and analyzed; furthermore,the protein expression levels of Piezo1,bone morphogenetic protein 2(BMP2),Runt-related transcription factor 2(Runx2),hypoxia-inducible factor-1α(HIF-1α),vascular endothelial growth factor(VEGF),and cluster of differentiation 31(CD31)/endomucin(EMCN)in femur head were detected.Results:①The results of observation on histopathological changes in femur head tissues of rats.In rats from blank group,the dense and well-arranged trabeculae were found within the femur heads; compared with that of blank group,the sparse,small,discontinuous and disordered arranged trabeculae were presented within the femur heads in rats of model group; compared with that of model group,the trabeculae increased and relatively neatly arranged within the femur heads in rats of WBVT group and Yoda1 group; whereas,compared with that of WBVT group,the trabeculae disorderedly arranged within the femur heads in rats of WBVT combined GsMTx4 group.Besides,the percentage of empty lacunae in femur head was higher in model group,WBVT group,Yoda1 group,WBVT combined GsMTx4 group compared to blank group(P=0.000,P=0.000,P=0.000,P=0.000),and was higher in model group compared to WBVT group and Yoda1 group(P=0.000,P=0.000),and was higher in WBVT combined GsMTx4 group compared to WBVT group(P=0.000).②The results of observation on bone microstructure of femur head in rats.The differences were not statistically significant in bone volume fraction(BVF),trabecular thickness(Tb.Th),trabecular number(Tb.N),and trabecular separation(Tb.Sp)of femur head between WBVT group and blank group,as well as between Yoda1 group and blank group(P=0.213,P=0.081,P=0.384,P=0.471; P=0.435,P=0.131,P=0.104,P=0.126).The BVF and Tb.Th were smaller,the Tb.N was fewer,while,the Tb.Sp was greater in model group and WBVT combined GsMTx4 group compared to blank group(P=0.000,P=0.000,P=0.000; P=0.000,P=0.000,P=0.000; P=0.000,P=0.000).The BVF and Tb.Th were greater,the Tb.N was more,while,the Tb.Sp was smaller in WBVT group and Yoda1 group compared to model group(P=0.000,P=0.002,P=0.000; P=0.000,P=0.007,P=0.014; P=0.000,P=0.000); while,the comparisons between WBVT group and Yoda1 group revealed no significant differences(P=0.194,P=0.223,P=0.332,P=0.071).Additionally,the BVF and Tb.Th were smaller,the Tb.N was fewer,while,the Tb.Sp was greater in WBVT combined GsMTx4 group compared to WBVT group(P=0.002,P=0.021,P=0.000,P=0.000).③The results of detection on the protein expression levels of Piezo1,BMP2,Runx2,HIF-1α and VEGF in femur head of rats.The differences were not statistically significant in the protein expression levels of Piezo1,BMP2,Runx2,HIF-1α and VEGF in femur head of rats between WBVT group and Yoda1 group(P=0.061,P=0.122,P=0.773,P=0.814,P=0.991; P=0.112,P=0.071,P=0.955,P=0.749,P=0.915); while,the protein expression levels of Piezo1,BMP2,Runx2,HIF-1α and VEGF in femur head of rats were lower in model group and WBVT combined GsMTx4 group compared to blank group(P=0.000,P=0.000,P=0.000,P=0.000,P=0.000; P=0.000,P=0.000,P=0.000,P=0.000,P=0.000).The protein expression levels of Piezo1,BMP2,Runx2,HIF-1α and VEGF in femur head of rats were higher in WBVT group and Yoda1 group compared to model group(P=0.000,P=0.000,P=0.000,P=0.000,P=0.000; P=0.000,P=0.000,P=0.000,P=0.000,P=0.000),while,the comparison between WBVT group and Yoda1 group revealed no significant differences(P=0.962,P=0.179,P=0.214,P=0.990,P=0.975).Additionally,the protein expression levels of Piezo1,BMP2,Runx2,HIF-1α and VEGF in femur head of rats were lower in WBVT combined GsMTx4 group compared to WBVT group(P=0.000,P=0.000,P=0.000,P=0.000,P=0.000).④The results of detection on the protein expression level of CD31/EMCN in femur head of rats.The protein expression level of CD31/EMCN in femur head of rats was lower in model group and WBVT combined GsMTx4 group compared to blank group(P=0.000,P=0.000),while,the comparisons between WBVT group and blank group,as well as between Yoda1 group and blank group revealed no significant differences(P=0.412,P=0.991).The protein expression level of CD31/EMCN in femur head of rats was higher in WBVT group and Yoda1 group compared to model group(P=0.000,P=0.000),while,was lower in WBVT combined GsMTx4 group compared to WBVT group(P=0.000).Conclusion:WBVT can promote the repair of necrotic tissues in femur head.It may work by affecting the HIF-1α/VEGF axis through up-regulating the expression of Piezo1 protein,thereby promoting the formation of type H blood vessels in femur head and improving the blood supply to the femur head.

參考文獻(xiàn)/References:

[1] 黃浩然,衛(wèi)楊文祥,章家皓,等.Piezo1介導(dǎo)的機(jī)械應(yīng)力刺激在抗骨質(zhì)疏松中的作用[J].中國組織工程研究,2023,27(17):2716-2722.
[2] 田佳慶,何敏聰,韋雨柔,等.激素性股骨頭壞死囊性變分布規(guī)律及病理特點(diǎn)[J].中國組織工程研究,2023,27(31):4996-5001.
[3] 李群,胡智星,張彥瓊,等.轉(zhuǎn)錄組學(xué)數(shù)據(jù)挖掘結(jié)合“臨床-動(dòng)物”研究驗(yàn)證識(shí)別激素性股骨頭壞死全病程的證素標(biāo)志基因[J].中國中藥雜志,2024,49(5):1343-1352.
[4] 劉凱,郭美玲,朱婷.振動(dòng)療法對(duì)骨質(zhì)疏松骨折患者骨礦含量、骨鈣素及骨折愈合的影響[J].中國現(xiàn)代醫(yī)學(xué)雜志,2023,33(15):8-14.
[5] 魏騰飛,何曉銘,韋雨柔,等.Piezo1在激素性和酒精性股骨頭壞死骨組織中的差異表達(dá)[J].中國組織工程研究,2023,27(2):270-275.
[6] TIAN J Q,WEI T F,WEI Y R,et al.Effect of whole body vibration therapy in the rat model of steroid-induced osteonecrosis of the femoral head[J].Front Cell Dev Biol,2023,11:1251634.
[7] 楊麗麗,康靜,劉建勛,等.Piezo1通道在心血管疾病中的作用及中醫(yī)藥研究進(jìn)展[J].中國中藥雜志,2022,47(24):6533-6540.
[8] 王媛,趙星成,王永春,等.Piezo通道在心血管系統(tǒng)中的作用[J].心臟雜志,2022,34(5):573-578.
[9] RANADE S S,QIU Z,WOO S H,et al.Piezo1,a mechanically activated ion channel,is required for vascular development in mice[J].Proc Natl Acad Sci U S A,2014,111(28):10347-10352.
[10] CHEN S,LI Z,CHEN D,et al.Piezo1-mediated mechanotransduction promotes entheseal pathological new bone formation in ankylosing spondylitis[J].Ann Rheum Dis,2023,82(4):533-545.
[11] 張曼,張苗苗,李易,等.牙齒移動(dòng)過程中Piezo1對(duì)壓力側(cè)牙周組織內(nèi)IL-1β、IL-6及IL-17的影響[J].口腔醫(yī)學(xué)研究,2023,39(2):135-140.
[12] 陳國輝,李亞星,張暉,等.Piezo機(jī)械敏感性離子通道在骨關(guān)節(jié)系統(tǒng)中的作用[J].中國修復(fù)重建外科雜志,2024,38(2):240-248.
[13] 韋雨柔,田佳慶,何憲順,等.慢病毒沉默Piezo1蛋白與人骨髓間充質(zhì)干細(xì)胞成骨分化及TAZ的表達(dá)[J].中國組織工程研究,2024,28(1):12-19.
[14] SUN W,CHI S,LI Y,et al.The mechanosensitive Piezo1 channel is required for bone formation[J].Elife,2019,8:e47454.
[15] DZAMUKOVA M,BRUNNER T M,MIOTLA-ZAREBSKA J,et al.Mechanical forces couple bone matrix mineralization with inhibition of angiogenesis to limit adolescent bone growth[J].Nat Commun,2022,13(1):3059.
[16] HU Y,TIAN H,CHEN W,et al.The critical role of the Piezo1/beta-catenin/ATF4 axis on the stemness of Gli1+ BMSCs during simulated microgravity-induced bone loss[J].Adv Sci(Weinh),2023,10(32):e2303375.
[17] LIU Y,TIAN H,HU Y,et al.Mechanosensitive Piezo1 is crucial for periosteal stem cell-mediated fracture healing[J].Int J Biol Sci,2022,18(10):3961-3980.
[18] RONG S,ZHANG L,WANG J,et al.Regulatory role of Piezo1 channel in endothelium-dependent hyperpolarization-mediated vasorelaxation of small resistance vessels and its anti-inflammatory action[J].Life Sci,2024,336:122326.
[19] DANIEL M,SHEPPARD N,CARLOS G,et al.H vessel formation as a marker for enhanced bone healing in irradiated distraction osteogenesis[J].Semin Plast Surg,2024,38(1):31-38.
[20] KUSUMBE A P,RAMASAMY S K,ADAMS R H.Coupling of angiogenesis and osteogenesis by a specific vessel subtype in bone[J].Nature,2014,507(7492):323-328.
[21] HUANG J,YIN H,RAO S S,et al.Harmine enhances type H vessel formation and prevents bone loss in ovariectomized mice[J].Theranostics,2018,8(9):2435-2446.
[22] LI X,FANG S,WANG S,et al.Hypoxia preconditioning of adipose stem cell-derived exosomes loaded in gelatin methacryloyl(GelMA)promote type H angiogenesis and osteoporotic fracture repair[J].J Nanobiotechnology,2024,22(1):112.
[23] WANG L,JIA P,SHAN Y,et al.Synergistic protection of bone vasculature and bone mass by desferrioxamine in osteoporotic mice[J].Mol Med Rep,2017,16(5):6642-6649.
[24] 上官文姬,張躍輝,岳江,等.柚皮苷通過HIF-1α/VEGF信號(hào)促進(jìn)H型血管抗骨質(zhì)疏松的研究[J].中國骨質(zhì)疏松雜志,2022,28(12):1755-1759.
[25] 于海洋,盧增鵬,汪海燕,等.激素性股骨頭壞死中Hif-1α/VEGF信號(hào)軸和H型血管改變的實(shí)驗(yàn)研究[J].中國實(shí)驗(yàn)動(dòng)物學(xué)報(bào),2022,30(6):759-766.
[26] 田佳慶,韋雨柔,肖方駿,等.虎杖苷調(diào)控HIF-1α/VEGF信號(hào)通路對(duì)絕經(jīng)后骨質(zhì)疏松癥大鼠H型血管生成的影響[J].中成藥,2024,46(5):1672-1676.

相似文獻(xiàn)/References:

[1]陳雷雷,張穎.何偉教授采用中醫(yī)藥療法治療股骨頭壞死的經(jīng)驗(yàn)[J].中醫(yī)正骨,2015,27(10):74.
[2]徐西林,趙永蘭,張曉峰,等.活骨注射液髖關(guān)節(jié)腔灌注對(duì)兔股骨頭壞死模型 血管內(nèi)皮生長(zhǎng)因子表達(dá)的動(dòng)態(tài)影響[J].中醫(yī)正骨,2015,27(08):1.
 XU Xilin,ZHAO Yonglan,ZHANG Xiaofeng,et al.Dynamic effect of intra-articular hip injection of Huogu injection on the expression of vascular endothelial growth factor in rabbit models with femur head necrosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(09):1.
[3]周勇,任菲菲,豐凡翔,等.血管內(nèi)皮生長(zhǎng)因子和骨形態(tài)發(fā)生蛋白2 在非創(chuàng)傷性股骨頭壞死不同區(qū)域的表達(dá)[J].中醫(yī)正骨,2015,27(08):7.
 ZHOU Yong,REN Feifei,FENG Fanxiang,et al.Expressions of vascular endothelial growth factor and bone morphogenetic protein 2 in different zones of femoral head with non-traumatic osteonecrosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(09):7.
[4]鮑榮華,王國平,夏曉斌,等.鉭棒植入治療非創(chuàng)傷性股骨頭壞死的療效觀察[J].中醫(yī)正骨,2015,27(02):28.
[5]張兵,馬凰富,劉波,等.非創(chuàng)傷性股骨頭壞死的舌象定量研究[J].中醫(yī)正骨,2015,27(04):8.
 ZHANG Bing,MA Huangfu,LIU Bo,et al.Quantitative study on tongue manifestation of patients with nontraumatic osteonecrosis of femoral head[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(09):8.
[6]李剛,程春生.股骨頭壞死血瘀證癥狀與平樂郭氏正骨方藥藥物組成 最大頻繁關(guān)聯(lián)模式挖掘[J].中醫(yī)正骨,2015,27(04):21.
 LI Gang,CHENG Chunsheng.Maximal frequent association pattern mining for studying the relationship between BLOOD STASIS syndrome in patients with osteonecrosis of femoral head and drug components of Pingle Guo's orthopedics prescription[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(09):21.
[7]李文龍,梅沉成,杜貴強(qiáng),等.微創(chuàng)減壓植骨多孔鉭棒植入治療 ARCOⅡ期非創(chuàng)傷性缺血性股骨頭壞死[J].中醫(yī)正骨,2016,28(02):43.
[8]張磊,金紅婷,童培建.骨健口服液早期干預(yù)非創(chuàng)傷性股骨頭壞死的臨床研究[J].中醫(yī)正骨,2016,28(03):14.
 ZHANG Lei,JIN Hongting,TONG Peijian.Clinical study on Gujian Koufuye(骨健口服液)for early intervention of nontraumatic osteonecrosis of femoral head[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(09):14.
[9]鮑榮華,王國平,夏曉斌,等.直接前入路微創(chuàng)全髖關(guān)節(jié)置換術(shù)治療晚期股骨頭壞死[J].中醫(yī)正骨,2016,28(03):61.
[10]張超,姚晨,沈計(jì)榮.微創(chuàng)髓芯減壓打壓支撐植骨術(shù)結(jié)合補(bǔ)腎活血湯口服治療ARCOⅡ、Ⅲ期股骨頭壞死的近期療效觀察[J].中醫(yī)正骨,2016,28(03):20.
 ZHANG Chao,YAO Chen,SHEN Jirong.[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(09):20.
[11]周占國,郭浩山,關(guān)濤,等.股骨頭壞死病因的相關(guān)因素分析[J].中醫(yī)正骨,2020,32(01):7.
[12]楊琪,杜炯,孫繼高,等.股骨頭壞死中醫(yī)證型分析[J].中醫(yī)正骨,2020,32(01):14.
[13]許珂,宇文星,宋夢(mèng)歌,等.股骨頭壞死全髖關(guān)節(jié)置換術(shù)患者的人群特征與臨床特點(diǎn)分析[J].中醫(yī)正骨,2020,32(01):51.
[14]李向洲,邢濤,張應(yīng)拴,等.中藥治療激素性股骨頭壞死作用機(jī)制的研究進(jìn)展[J].中醫(yī)正骨,2023,35(02):33.
[15]楊博,邢濤,張應(yīng)拴,等.從伏邪理論論治激素性股骨頭壞死[J].中醫(yī)正骨,2023,35(02):54.
[16]方偉華,莊至坤,彭鵬,等.激素性股骨頭壞死滑膜病變分子機(jī)制的實(shí)驗(yàn)研究[J].中醫(yī)正骨,2024,36(09):49.
 FANG Weihua,ZHUANG Zhikun,PENG Peng,et al.Molecular mechanisms of synovial lesions in steroid-induced osteonecrosis of the femoral head:an experimental study[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2024,36(09):49.
[17]彭鵬,肖歡,方偉華,等.激素性股骨頭壞死囊性變組織骨修復(fù)機(jī)制分析與活血通絡(luò)膠囊含藥血清對(duì)肥大軟骨細(xì)胞成骨分化影響的實(shí)驗(yàn)研究[J].中醫(yī)正骨,2024,36(09):19.
 PENG Peng,XIAO Huan,FANG Weihua,et al.[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2024,36(09):19.

備注/Memo

備注/Memo:
基金項(xiàng)目:國家自然科學(xué)基金項(xiàng)目(82274544,82004392); 廣東省基礎(chǔ)與應(yīng)用基礎(chǔ)研究基金項(xiàng)目(2023A1515010551); 廣東省中醫(yī)骨傷研究院開放課題重點(diǎn)項(xiàng)目(GYH202101-01,GYH202101-04)
通訊作者:魏秋實(shí) E-mail:[email protected]
更新日期/Last Update: 1900-01-01